The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Act" was unveiled by a group of bipartisan lawmakers Tuesday, aimed at reforming the incentive structure for Pharmacy Benefit ...

For decades, the United States has led the world in pharmaceutical innovation -- developing drugs that combat cancer, heart ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Bill would rein in “pharmacy benefit managers,” or PBMs, which have come under fire for driving up prescription drug costs ...

Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.